|
1
|
Plebani M, Cadamuro J, Vermeersch P, Jovičić S, Ozben T, Trenti T, McMillan B, Lowe CR, Lennerz J, Macintyre E, Gabelli C, Sandberg S, Padoan A, Wiencek JR, Banfi G, Lubin IM, Orth M, Carobene A, Zima T, Cobbaert CM, van Schaik RHN, Lippi G. A vision to the future: value-based laboratory medicine. Clin Chem Lab Med 2024; 62:2373-2387. [PMID: 39259894 DOI: 10.1515/cclm-2024-1022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2024] [Accepted: 09/02/2024] [Indexed: 09/13/2024]
Abstract
The ultimate goal of value-based laboratory medicine is maximizing the effectiveness of laboratory tests in improving patient outcomes, optimizing resources and minimizing unnecessary costs. This approach abandons the oversimplified notion of test volume and cost, in favor of emphasizing the clinical utility and quality of diagnostic tests in the clinical decision-making. Several key elements characterize value-based laboratory medicine, which can be summarized in some basic concepts, such as organization of in vitro diagnostics (including appropriateness, integrated diagnostics, networking, remote patient monitoring, disruptive innovations), translation of laboratory data into clinical information and measurable outcomes, sustainability, reimbursement, ethics (e.g., patient empowerment and safety, data protection, analysis of big data, scientific publishing). Education and training are also crucial, along with considerations for the future of the profession, which will be largely influenced by advances in automation, information technology, artificial intelligence, and regulations concerning in vitro diagnostics. This collective opinion paper, composed of summaries from presentations given at the two-day European Federation of Laboratory Medicine (EFLM) Strategic Conference "A vision to the future: value-based laboratory medicine" (Padova, Italy; September 23-24, 2024), aims to provide a comprehensive overview of value-based laboratory medicine, projecting the profession into a more clinically effective and sustainable future.
Collapse
Affiliation(s)
- Mario Plebani
- Department of Laboratory Medicine, University of Padova, Padova, Italy
| | - Janne Cadamuro
- Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria
| | - Pieter Vermeersch
- Clinical Department of Laboratory Medicine, UZ Leuven, Leuven, Belgium
| | - Snežana Jovičić
- Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
| | - Tomris Ozben
- Medical Faculty, Department of Medical Biochemistry, Akdeniz University, Antalya, Türkiye
- Medical Faculty, Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy
| | | | - Brian McMillan
- Centre of Primary Care and Health Services Research, University of Manchester, Manchester, UK
| | | | | | - Elizabeth Macintyre
- Onco-Hematology Laboratory, Necker Hospital and Université Paris Cité, Paris, France
| | - Carlo Gabelli
- Research Centre for Brain Aging (CRIC), University Hospital of Padua, Padova, Italy
| | | | - Andrea Padoan
- Department of Medicine, University of Padova, Padova, Italy
- Laboratory Medicine Unit, University-Hospital of Padova, Padova, Italy
| | - Joesph R Wiencek
- Department of Pathology, Microbiology, and Immunology, Vanderbilt School of Medicine, Nashville, TN, USA
| | - Giuseppe Banfi
- IRCCS Galeazzi Sant'Ambrogio, Milan, Italy
- University Vita e Salute San Raffaele, Milan, Italy
| | - Ira M Lubin
- Division of Laboratory Systems, Center for Laboratory Systems and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | - Matthias Orth
- Medical Faculty of Mannheim, Vinzenz von Paul Kliniken gGmbH, Stuttgart, Germany
- Heidelberg University, Heidelberg, Germany
| | - Anna Carobene
- Laboratory Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Tomáš Zima
- Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
| | - Christa M Cobbaert
- Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands
- EFLM Committee on European Regulatory Affairs and EFLM Liaison to BioMed Alliance in Europe, Brussels, Belgium
| | - Ron H N van Schaik
- Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, The Netherlands
| | - Giuseppe Lippi
- Section of Clinical Biochemistry, University of Verona, Verona, Italy
| |
Collapse
|